Immunetics Inc., a Boston company focused on technologies for diagnosing and screening for infectious diseases, said Monday that its board of directors has appointed John Yonkin as chief executive. Yonkin succeeds Dr. Andrew Levin, the company’s founder. Levin will remain president at Immunetics and will continue to lead its research and development group.
Unlimited access to BostonGlobe.com for only 99 cents for the first 4 weeks.Sign up
Are you a home delivery subscriber?
Get FREE access as part of your print subscriptionStart Here
Contact us for help